Chlamydia Diagnostics Market is anticipated to reach US$ 3.69 billion by 2033
The global Chlamydia Diagnostics market revenue is expected to reach US$ 3.69 billion by 2033. The market’s expansion could be attributed to growing awareness of the importance of STI testing.The Chlamydia Diagnostics market in Europe is expected to grow rapidly in the next years due to a variety of causes. The incr...
New York United States Teva Pharmaceuticals Quidel Corporation Abbott Laboratories European Centre For Disease Prevention
Source: pharmiweb.com